FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004387611> ?p ?o ?g. }

• W2004387611 endingPage "16097" @default.
• W2004387611 startingPage "16085" @default.
• W2004387611 abstract "The stem cell in the isthmus of gastric units continually replenishes the epithelium. Atrophy of acid-secreting parietal cells (PCs) frequently occurs during infection with Helicobacter pylori, predisposing patients to cancer. Atrophy causes increased proliferation of stem cells, yet little is known about how this process is regulated. Here we show that CD44 labels a population of small, undifferentiated cells in the gastric unit isthmus where stem cells are known to reside. Loss of CD44 in vivo results in decreased proliferation of the gastric epithelium. When we induce PC atrophy by Helicobacter infection or tamoxifen treatment, this CD44+ population expands from the isthmus toward the base of the unit. CD44 blockade during PC atrophy abrogates the expansion. We find that CD44 binds STAT3, and inhibition of either CD44 or STAT3 signaling causes decreased proliferation. Atrophy-induced CD44 expansion depends on pERK, which labels isthmal cells in mice and humans. Our studies delineate an in vivo signaling pathway, ERK → CD44 → STAT3, that regulates normal and atrophy-induced gastric stem/progenitor-cell proliferation. We further show that we can intervene pharmacologically at each signaling step in vivo to modulate proliferation.Background: Gastric parietal cell atrophy causes metaplasia, reactive stem cell proliferation, and increased risk for cancer.Results: Atrophy induces proliferation of CD44-positive epithelial cells that requires ERK → CD44 → STAT3 signaling.Conclusion: CD44 is a putative gastric stem cell marker that regulates normal and metaplasia-associated proliferation.Significance: Targeted pharmacological inhibition of ERK/CD44/STAT3 signaling may help block or reverse proliferation in precancerous atrophic/metaplastic lesions. The stem cell in the isthmus of gastric units continually replenishes the epithelium. Atrophy of acid-secreting parietal cells (PCs) frequently occurs during infection with Helicobacter pylori, predisposing patients to cancer. Atrophy causes increased proliferation of stem cells, yet little is known about how this process is regulated. Here we show that CD44 labels a population of small, undifferentiated cells in the gastric unit isthmus where stem cells are known to reside. Loss of CD44 in vivo results in decreased proliferation of the gastric epithelium. When we induce PC atrophy by Helicobacter infection or tamoxifen treatment, this CD44+ population expands from the isthmus toward the base of the unit. CD44 blockade during PC atrophy abrogates the expansion. We find that CD44 binds STAT3, and inhibition of either CD44 or STAT3 signaling causes decreased proliferation. Atrophy-induced CD44 expansion depends on pERK, which labels isthmal cells in mice and humans. Our studies delineate an in vivo signaling pathway, ERK → CD44 → STAT3, that regulates normal and atrophy-induced gastric stem/progenitor-cell proliferation. We further show that we can intervene pharmacologically at each signaling step in vivo to modulate proliferation. Background: Gastric parietal cell atrophy causes metaplasia, reactive stem cell proliferation, and increased risk for cancer. Results: Atrophy induces proliferation of CD44-positive epithelial cells that requires ERK → CD44 → STAT3 signaling. Conclusion: CD44 is a putative gastric stem cell marker that regulates normal and metaplasia-associated proliferation. Significance: Targeted pharmacological inhibition of ERK/CD44/STAT3 signaling may help block or reverse proliferation in precancerous atrophic/metaplastic lesions." @default.
• W2004387611 created "2016-06-24" @default.
• W2004387611 creator A5004814157 @default.
• W2004387611 creator A5045575840 @default.
• W2004387611 creator A5046301295 @default.
• W2004387611 creator A5046720476 @default.
• W2004387611 creator A5047989998 @default.
• W2004387611 creator A5050074834 @default.
• W2004387611 creator A5074449918 @default.
• W2004387611 creator A5085882005 @default.
• W2004387611 creator A5086932115 @default.
• W2004387611 creator A5086954734 @default.
• W2004387611 date "2013-05-01" @default.
• W2004387611 modified "2023-10-16" @default.
• W2004387611 title "The Hyaluronic Acid Receptor CD44 Coordinates Normal and Metaplastic Gastric Epithelial Progenitor Cell Proliferation" @default.
• W2004387611 cites W1507611751 @default.
• W2004387611 cites W1545715882 @default.
• W2004387611 cites W1556659072 @default.
• W2004387611 cites W1578826975 @default.
• W2004387611 cites W1859808324 @default.
• W2004387611 cites W1894322179 @default.
• W2004387611 cites W1969321239 @default.
• W2004387611 cites W1969980017 @default.
• W2004387611 cites W1976458320 @default.
• W2004387611 cites W1976671493 @default.
• W2004387611 cites W1979287862 @default.
• W2004387611 cites W1981989535 @default.
• W2004387611 cites W1985404327 @default.
• W2004387611 cites W1988155417 @default.
• W2004387611 cites W1995737296 @default.
• W2004387611 cites W2002416520 @default.
• W2004387611 cites W2003299661 @default.
• W2004387611 cites W2003605454 @default.
• W2004387611 cites W2003676563 @default.
• W2004387611 cites W2006696441 @default.
• W2004387611 cites W2009343546 @default.
• W2004387611 cites W2009748726 @default.
• W2004387611 cites W2020009452 @default.
• W2004387611 cites W2020743730 @default.
• W2004387611 cites W2023117020 @default.
• W2004387611 cites W2023377449 @default.
• W2004387611 cites W2024520801 @default.
• W2004387611 cites W2029155462 @default.
• W2004387611 cites W2030408713 @default.
• W2004387611 cites W2032205189 @default.
• W2004387611 cites W2035184087 @default.
• W2004387611 cites W2038264502 @default.
• W2004387611 cites W2040964382 @default.
• W2004387611 cites W2041399911 @default.
• W2004387611 cites W2044022855 @default.
• W2004387611 cites W2051261247 @default.
• W2004387611 cites W2056630969 @default.
• W2004387611 cites W2059574805 @default.
• W2004387611 cites W2061928622 @default.
• W2004387611 cites W2062165914 @default.
• W2004387611 cites W2069849932 @default.
• W2004387611 cites W2075890816 @default.
• W2004387611 cites W2076158851 @default.
• W2004387611 cites W2076243351 @default.
• W2004387611 cites W2078310910 @default.
• W2004387611 cites W2080844302 @default.
• W2004387611 cites W2083583542 @default.
• W2004387611 cites W2086892678 @default.
• W2004387611 cites W2091347891 @default.
• W2004387611 cites W2097387056 @default.
• W2004387611 cites W2097709883 @default.
• W2004387611 cites W2098837984 @default.
• W2004387611 cites W2104818946 @default.
• W2004387611 cites W2105002552 @default.
• W2004387611 cites W2107398189 @default.
• W2004387611 cites W2107884498 @default.
• W2004387611 cites W2112979582 @default.
• W2004387611 cites W2117113786 @default.
• W2004387611 cites W2118831064 @default.
• W2004387611 cites W2119390568 @default.
• W2004387611 cites W2123873958 @default.
• W2004387611 cites W2134709252 @default.
• W2004387611 cites W2135087664 @default.
• W2004387611 cites W2135157964 @default.
• W2004387611 cites W2137586381 @default.
• W2004387611 cites W2138964273 @default.
• W2004387611 cites W2139151018 @default.
• W2004387611 cites W2147705631 @default.
• W2004387611 cites W2148553058 @default.
• W2004387611 cites W2149070581 @default.
• W2004387611 cites W2151386694 @default.
• W2004387611 cites W2151513527 @default.
• W2004387611 cites W2152314991 @default.
• W2004387611 cites W2156149964 @default.
• W2004387611 cites W2156315689 @default.
• W2004387611 cites W2164348684 @default.
• W2004387611 doi "https://doi.org/10.1074/jbc.m112.445551" @default.
• W2004387611 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3668764" @default.
• W2004387611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23589310" @default.
• W2004387611 hasPublicationYear "2013" @default.
• W2004387611 type Work @default.
• W2004387611 sameAs 2004387611 @default.
• W2004387611 citedByCount "93" @default.

• next